Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Valneva SE (NASDAQ:VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001.
- The data show that a booster dose of VLA2001 was well tolerated in previously vaccinated participants with either Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) or Moderna Inc (NASDAQ:MRNA) shots.
- The data confirm the favorable safety profile of VLA2001 seen across all studies, including in homologous or heterologous booster settings.
- However, in this study, an additional booster dose of VLA2001 elicited only a marginally increased neutralizing antibody response, Valneva added.
- Also see: France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine.
- The company previously reported positive heterologous booster results following primary vaccination with AstraZeneca Plc's (NASDAQ:AZN) vaccine - in August 2022 and positive homologous booster results at the end of December 2021.
- Valneva is currently seeking regulatory approval for VLA2001 as a homologous and heterologous booster in AstraZeneca - primed individuals who may support the company deploying its inventory in international markets.
- Price Action: VALN shares closed at $12.72 on Friday.
- Photo Via Wikimedia Commons
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!